Cargando…

Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model

PURPOSE: We evaluate the feasibility of the elective nodal irradiation strategy in stereotactic body radiotherapy (SBRT) for pancreatic cancer. METHODS: Three simultaneous integrated boost (SIB)‐SBRT plans (Boost1, Boost2, and Boost3) were retrospectively generated for each of 20 different patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Akira, Prichard, Hugh A., Wo, Jennifer Y., Wolfgang, John A., Hong, Theodore S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370996/
https://www.ncbi.nlm.nih.gov/pubmed/30636367
http://dx.doi.org/10.1002/acm2.12528
_version_ 1783394472150695936
author Nakamura, Akira
Prichard, Hugh A.
Wo, Jennifer Y.
Wolfgang, John A.
Hong, Theodore S.
author_facet Nakamura, Akira
Prichard, Hugh A.
Wo, Jennifer Y.
Wolfgang, John A.
Hong, Theodore S.
author_sort Nakamura, Akira
collection PubMed
description PURPOSE: We evaluate the feasibility of the elective nodal irradiation strategy in stereotactic body radiotherapy (SBRT) for pancreatic cancer. METHODS: Three simultaneous integrated boost (SIB)‐SBRT plans (Boost1, Boost2, and Boost3) were retrospectively generated for each of 20 different patients. Boost1 delivered 33 and 25 Gy to PTV1 and PTV2, respectively. Boost2 delivered 40, 33, and 25 Gy to boostCTV, PTV1, and PTV2, respectively. Boost3 delivered 33 and 25 Gy to PTV1 and PTV3, respectively. PTV1 covered the initial standard SBRT plan (InitPlan) gross tumor volume (GTV). PTV2 covered CTVgeom which was created by a 10‐mm expansion (15 mm posterior) of GTV. PTV3 covered CTVprop which included elective nodal regions. The boostCTV included GTV as well as involved vasculature. The planning feasibility in each scenario and dose–volume histograms (DVHs) were analyzed and compared with the InitPlan (delivered 33 Gy only to PTV1) by paired t‐test. Next, a novel DVH prediction model was developed and its performance was evaluated according to the prediction accuracy (AC) of planning violations. Then, the model was used to simulate the impacts of GTV‐to‐organs at risk (OAR) distance and gastrointestinal (GI) OAR volume variations on planning feasibility. RESULTS: Significant dose increases were observed in GI‐OARs in SIB‐SBRT plans when compared with InitPlan. All dose constraints were met in 63% of cases in InitPlan, Boost1, and Boost2, whereas Boost3 developed DVH violations in all cases. Utilizing previous patient anatomy, the novel DVH prediction model achieved a high AC in the prediction of violations for GI‐OARs; the positive predictive value, negative predictive value, and AC were 66%, 90%, and 84%, respectively. Experiments with the model demonstrated that the larger proximity volume of GI‐OAR at the shorter distance substantially impacted on planning violations. CONCLUSIONS: SIB‐SBRT plan with geometrically defined prophylactic areas can be dosimetrically feasible, but including all nodal areas with 25 Gy in five fractions appears to be unrealistic.
format Online
Article
Text
id pubmed-6370996
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63709962019-02-21 Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model Nakamura, Akira Prichard, Hugh A. Wo, Jennifer Y. Wolfgang, John A. Hong, Theodore S. J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: We evaluate the feasibility of the elective nodal irradiation strategy in stereotactic body radiotherapy (SBRT) for pancreatic cancer. METHODS: Three simultaneous integrated boost (SIB)‐SBRT plans (Boost1, Boost2, and Boost3) were retrospectively generated for each of 20 different patients. Boost1 delivered 33 and 25 Gy to PTV1 and PTV2, respectively. Boost2 delivered 40, 33, and 25 Gy to boostCTV, PTV1, and PTV2, respectively. Boost3 delivered 33 and 25 Gy to PTV1 and PTV3, respectively. PTV1 covered the initial standard SBRT plan (InitPlan) gross tumor volume (GTV). PTV2 covered CTVgeom which was created by a 10‐mm expansion (15 mm posterior) of GTV. PTV3 covered CTVprop which included elective nodal regions. The boostCTV included GTV as well as involved vasculature. The planning feasibility in each scenario and dose–volume histograms (DVHs) were analyzed and compared with the InitPlan (delivered 33 Gy only to PTV1) by paired t‐test. Next, a novel DVH prediction model was developed and its performance was evaluated according to the prediction accuracy (AC) of planning violations. Then, the model was used to simulate the impacts of GTV‐to‐organs at risk (OAR) distance and gastrointestinal (GI) OAR volume variations on planning feasibility. RESULTS: Significant dose increases were observed in GI‐OARs in SIB‐SBRT plans when compared with InitPlan. All dose constraints were met in 63% of cases in InitPlan, Boost1, and Boost2, whereas Boost3 developed DVH violations in all cases. Utilizing previous patient anatomy, the novel DVH prediction model achieved a high AC in the prediction of violations for GI‐OARs; the positive predictive value, negative predictive value, and AC were 66%, 90%, and 84%, respectively. Experiments with the model demonstrated that the larger proximity volume of GI‐OAR at the shorter distance substantially impacted on planning violations. CONCLUSIONS: SIB‐SBRT plan with geometrically defined prophylactic areas can be dosimetrically feasible, but including all nodal areas with 25 Gy in five fractions appears to be unrealistic. John Wiley and Sons Inc. 2019-01-13 /pmc/articles/PMC6370996/ /pubmed/30636367 http://dx.doi.org/10.1002/acm2.12528 Text en © 2019 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Nakamura, Akira
Prichard, Hugh A.
Wo, Jennifer Y.
Wolfgang, John A.
Hong, Theodore S.
Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model
title Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model
title_full Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model
title_fullStr Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model
title_full_unstemmed Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model
title_short Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model
title_sort elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: analyses of planning feasibility and geometrically driven dvh prediction model
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370996/
https://www.ncbi.nlm.nih.gov/pubmed/30636367
http://dx.doi.org/10.1002/acm2.12528
work_keys_str_mv AT nakamuraakira electivenodalirradiationwithsimultaneousintegratedbooststereotacticbodyradiotherapyforpancreaticcanceranalysesofplanningfeasibilityandgeometricallydrivendvhpredictionmodel
AT prichardhugha electivenodalirradiationwithsimultaneousintegratedbooststereotacticbodyradiotherapyforpancreaticcanceranalysesofplanningfeasibilityandgeometricallydrivendvhpredictionmodel
AT wojennifery electivenodalirradiationwithsimultaneousintegratedbooststereotacticbodyradiotherapyforpancreaticcanceranalysesofplanningfeasibilityandgeometricallydrivendvhpredictionmodel
AT wolfgangjohna electivenodalirradiationwithsimultaneousintegratedbooststereotacticbodyradiotherapyforpancreaticcanceranalysesofplanningfeasibilityandgeometricallydrivendvhpredictionmodel
AT hongtheodores electivenodalirradiationwithsimultaneousintegratedbooststereotacticbodyradiotherapyforpancreaticcanceranalysesofplanningfeasibilityandgeometricallydrivendvhpredictionmodel